Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas
By Gabby Migliara | August 12, 2020
According to a recent IQVIA analysis, commercial health plans have increased patients’ average out-of-pocket costs for brand medicines by over 50% in some therapeutic areas since 2015. Notably, of...
Read More
PhRMA comments to Congress on Cures 2.0 call to action
By Anne McDonald Pritchett, PhD | December 18, 2019
As new therapies continue to revolutionize the treatment of many diseases, it is positive news that policymakers in Washington are discussing ways to ensure patient access to new treatments and...
Read More
Ask About Adherence: Hepatitis C cures will save Medicaid $12 billion by 2022
By Katie Koziara | June 21, 2019
Ask About Adherence is a blog series featuring Q&A’s with experts and new medication adherence resources. In this post, we feature a recent study on the savings associated with new hepatitis C...
Read More
OptumRX: Sharing rebates with patients is “worth it”
By Holly Campbell | March 18, 2019
PhRMA has long advocated for sharing the $166 billion in rebates and discounts given by biopharmaceutical companies to the government, insurers, and pharmacy benefit managers (PBMs) with patients...
Read More
Ask About Adherence: Private-sector collaboration can lead to savings and care improvement
By Carolyn Ha | January 25, 2018
Ask About Adherence is a blog series featuring Q&A’s with experts and new medication adherence resources. In this post, we feature a recent study on medication non-adherence and discuss how a safe...
Read More
New report shows better diabetes management saves money and improves patient outcomes
By Carolyn Ha | November 21, 2017
A recent IHS Markit report, “The Clinical and Economic Benefits of Better Treatment of Adult Medicaid Beneficiaries with Diabetes,” simulated savings in the Medicaid program as a result of better...
Read More
Protect your health: Important disaster preparedness tips for Harvey and Irma
By Guest Contributor | September 6, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Ask About Adherence: Discussion on medication adherence as national priority
By Guest Contributor | June 21, 2017
Ask About Adherence is a blog series featuring discussions with experts and new medication adherence resources. In this post, Sloane Salzburg, M.S, executive director of Prescriptions for a...
Read More
Medicare Monday: Positive impact of Part D on America’s seniors
By Nicole Longo | June 5, 2017
Implementation of Medicare Part D significantly increased access to medicines for seniors and for those under age 65 with permanent disabilities. Since then, Part D has contributed to significant...
Read More
A critical opportunity to prevent prescription drug abuse
By Anne McDonald Pritchett, PhD | June 2, 2017
U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb recently cited addressing the opioid crisis as his highest priority. As someone who has spent the bulk of my career focused on...
Read More
Medicare Monday (100)
340B Spotlight (43)
Cost & Consequence (0)
